JOSÉ ÁNGEL
HERNÁNDEZ RIVAS

Profesor asociado

Foto de JOSÉ ÁNGEL

Foto de Hospital Universitari de Tarragona Joan XXIII

Hospital Universitari de Tarragona Joan XXIII

Tarragona, España

Publicaciones en colaboración con investigadores/as de Hospital Universitari de Tarragona Joan XXIII (4)

2024

Correction to: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA (Scientific Reports, (2022), 12, 1, (13057), 10.1038/s41598-022-17271-3)
Scientific Reports

2023

Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma
Annals of Hematology, Vol. 102, Núm. 2, pp. 429-437

2022

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
Scientific Reports, Vol. 12, Núm. 1

2013

Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab)
Cancer, Vol. 119, Núm. 9, pp. 1660-1668